Proton Therapy Systems Market 2022
Growing prevalence of cancer has prompted medical organizations towards development and adoption of advanced treatment procedures, such as proton radiotherapy. The effectiveness of proton therapy continues to gain trust of cancer patients across the globe. The procedure is known for successfully destructing tumor cells by damaging their DNA through a targeted deposition of high-energy radiation dosage onto the tumor.
Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/12358
Furthermore, doctors treating cancer patients are also benefiting from the feasibility of proton therapy as it can be used in conjunction with other treatments. Factors as such continue to promote the adoption of proton therapy for curing cancerous abnormalities. Persistence Market Research projects that by the end of 2027, the global market for proton therapy will bring in more than US$ 2,926.7 Mn in revenues.
Company Profiles
- Hitachi Ltd.
- Ion Beam Applications SA
- Mevion Medical Systems
- Mitsubishi Electric Corporation
- ProNova Solutions, LLC
- ProTom International
- Sumitomo Heavy Industries Ltd.
- Varian Medical Systems
Request for Methodology@ https://www.persistencemarketresearch.com/methodology/12358
In the report, titled “Proton Therapy Market: Global Industry Analysis and Forecast, 2016-2024,” the global market for proton therapy is presently valued at closed to US$ 945 Mn and is projected to soar at a healthy CAGR of 15.2%. The report estimates that governments from all corners of the globe will continue to shore up their healthcare expenditure on cancer care facilities, which will incidentally boost the revenues in global proton therapy market. Additional benefits of availing proton therapy, compared to chemotherapy or radiation therapy, will also instrument a steadfast revenue growth for the market.
Based on a regional analysis compiled in the report, North America is projected to account for a little less than one-third share of global proton therapy revenues throughout the forecast period. However, Europe’s proton therapy market will dominate with close to 38% share and showcase revenue growth at 15.7% CAGR.
Access Full Report@ https://www.persistencemarketresearch.com/checkout/12358
Report Highlights:
- Detailed overview of parent market
- Changing market dynamics of the industry
- In-depth market segmentation
- Historical, current and projected market size in terms of value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and product offerings
- Potential and niche segments/regions exhibiting promising growth
- A neutral perspective towards market performance
- Must-have information for market players to sustain and enhance their market footprint
About us: Persistence Market Research
Contact us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com